177 related articles for article (PubMed ID: 37936126)
41. Predictors of long-term survival after pancreaticoduodenectomy for peri-ampullary adenocarcinoma: A retrospective study of 5-year survivors.
El Nakeeb A; El Sorogy M; Ezzat H; Said R; El Dosoky M; Abd El Gawad M; Elsabagh AM; El Hanafy E
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):443-449. PubMed ID: 30126828
[TBL] [Abstract][Full Text] [Related]
42. Clinicopathological Stratification and Long-term Follow-up of Patients with Periampullary Carcinomas.
Schmuck RB; Brokat C; Andreou A; Felsenstein M; Klein F; Sinn B; Pratschke J; Bahra M
Anticancer Res; 2018 Sep; 38(9):5379-5386. PubMed ID: 30194192
[TBL] [Abstract][Full Text] [Related]
43. The aborted Whipple: Why, and what happens next?
Shah MM; Ajay PS; Meltzer RS; Jajja MR; Gullickson CR; Cardona K; Russell MC; Sarmiento JM; Maithel SK; Kooby DA
J Surg Oncol; 2022 Mar; 125(4):642-645. PubMed ID: 35015302
[TBL] [Abstract][Full Text] [Related]
44. Association of Histopathologic Phenotype of Periampullary Adenocarcinomas With Survival.
Williams JL; Chan CK; Toste PA; Elliott IA; Vasquez CR; Sunjaya DB; Swanson EA; Koo J; Hines OJ; Reber HA; Dawson DW; Donahue TR
JAMA Surg; 2017 Jan; 152(1):82-88. PubMed ID: 27732711
[TBL] [Abstract][Full Text] [Related]
45. Diagnostic and therapeutic dilemmas in periampullary lesions.
Tsai PJ; Wang SE; Shyr YM; Chen TH; Su CH; Wu CW
Hepatogastroenterology; 2012; 59(117):1621-5. PubMed ID: 22683981
[TBL] [Abstract][Full Text] [Related]
46. The impact of cancer treatment on quality of life in patients with pancreatic and periampullary cancer: a propensity score matched analysis.
Mackay TM; Dijksterhuis WPM; Latenstein AEJ; van der Geest LG; Sprangers MAG; van Eijck CHJ; Homs MYV; Luelmo SAC; Molenaar IQ; van Santvoort H; Schreinemakers JMJ; Wilmink JW; Besselink MG; van Laarhoven HW; van Oijen MGH;
HPB (Oxford); 2022 Apr; 24(4):443-451. PubMed ID: 34635432
[TBL] [Abstract][Full Text] [Related]
47. Opportunities of improvement in the management of pancreatic and periampullary tumors.
Nordby T; Ikdahl T; Lothe IM; Ånonsen K; Hauge T; Edwin B; Line PD; Labori KJ; Buanes T
Scand J Gastroenterol; 2013 May; 48(5):617-25. PubMed ID: 23597153
[TBL] [Abstract][Full Text] [Related]
48. Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
Yeo CJ; Cameron JL; Lillemoe KD; Sohn TA; Campbell KA; Sauter PK; Coleman J; Abrams RA; Hruban RH
Ann Surg; 2002 Sep; 236(3):355-66; discussion 366-8. PubMed ID: 12192322
[TBL] [Abstract][Full Text] [Related]
49. Carcinoma of the pancreatic head and periampullary region. Tumor staging with laparoscopy and laparoscopic ultrasonography.
John TG; Greig JD; Carter DC; Garden OJ
Ann Surg; 1995 Feb; 221(2):156-64. PubMed ID: 7857143
[TBL] [Abstract][Full Text] [Related]
50. Intensified adjuvant combined modality therapy for resected periampullary adenocarcinoma: acceptable toxicity and suggestion of improved 1-year disease-free survival.
Chakravarthy A; Abrams RA; Yeo CJ; Korman LT; Donehower RC; Hruban RH; Zahurek ML; Grochow LB; O'Reilly S; Hurwitz H; Jaffee EM; Lillemoe KD; Cameron JL
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1089-96. PubMed ID: 11072167
[TBL] [Abstract][Full Text] [Related]
51. Ampullary and periampullary adenocarcinoma: new challenges in management of recurrence.
Ramfidis VS; Syrigos KN; Saif MW
JOP; 2013 Mar; 14(2):158-60. PubMed ID: 23474562
[TBL] [Abstract][Full Text] [Related]
52. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial.
Neoptolemos JP; Moore MJ; Cox TF; Valle JW; Palmer DH; McDonald AC; Carter R; Tebbutt NC; Dervenis C; Smith D; Glimelius B; Charnley RM; Lacaine F; Scarfe AG; Middleton MR; Anthoney A; Ghaneh P; Halloran CM; Lerch MM; Oláh A; Rawcliffe CL; Verbeke CS; Campbell F; Büchler MW;
JAMA; 2012 Jul; 308(2):147-56. PubMed ID: 22782416
[TBL] [Abstract][Full Text] [Related]
53. Differential expressions of cyclin D1 associated with better prognosis of cancers of ampulla of Vater.
Chang MC; Chang YT; Sun CT; Chiu YF; Lin JT; Tien YW
World J Surg; 2007 May; 31(5):1135-41. PubMed ID: 17420962
[TBL] [Abstract][Full Text] [Related]
54. Differential diagnosis of pancreatic cancer from other solid tumours arising from the periampullary area on MDCT.
Jang SK; Kim JH; Joo I; Jeon JH; Shin KS; Han JK; Choi BI
Eur Radiol; 2015 Oct; 25(10):2880-8. PubMed ID: 25916385
[TBL] [Abstract][Full Text] [Related]
55. Prognostic value of CA 19-9, CEA, CRP, LDH and bilirubin levels in locally advanced and metastatic pancreatic cancer: results from a multicenter, pooled analysis of patients receiving palliative chemotherapy.
Haas M; Heinemann V; Kullmann F; Laubender RP; Klose C; Bruns CJ; Holdenrieder S; Modest DP; Schulz C; Boeck S
J Cancer Res Clin Oncol; 2013 Apr; 139(4):681-9. PubMed ID: 23315099
[TBL] [Abstract][Full Text] [Related]
56. [CT-guided percutaneous fine needle aspiration cytodiagnosis of pancreatic and periampullary tumors].
Jia ZG; Pan RQ; Liu DH
Zhonghua Zhong Liu Za Zhi; 1987 Mar; 9(2):124-6. PubMed ID: 3652914
[TBL] [Abstract][Full Text] [Related]
57. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
[TBL] [Abstract][Full Text] [Related]
58. Expression of p16 protein and cyclin D1 in periampullary carcinomas.
Tuncer E; Türk NS; Arici S; Düzcan SE; Demirkan NC
Turk Patoloji Derg; 2011 Jan; 27(1):17-22. PubMed ID: 21469422
[TBL] [Abstract][Full Text] [Related]
59. Prognostic effect of hENT1, dCK and HuR expression by morphological type in periampullary adenocarcinoma, including pancreatic cancer.
Elebro J; Ben Dror L; Heby M; Nodin B; Jirström K; Eberhard J
Acta Oncol; 2016; 55(3):286-96. PubMed ID: 26362587
[TBL] [Abstract][Full Text] [Related]
60. Pancreatic cancer surgery in elderly patients: Balancing between short-term harm and long-term benefit. A population-based study in the Netherlands.
van der Geest LG; Besselink MG; van Gestel YR; Busch OR; de Hingh IH; de Jong KP; Molenaar IQ; Lemmens VE
Acta Oncol; 2016; 55(3):278-85. PubMed ID: 26552841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
